Publications Database

Hoshino Y. et al. (1977)

The effects of methylphenidate on early infantile autism and its relation to serum serotonin levels.

Folia Psychiatrica et Neurologica Japonica

31(4), pp. 605-614

Read Abstract (New Window)

Ishitobi M. et al. (2013)

Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.

Clinical Neuropharmacology

September, 36(5), pp. 151-156.

Read Abstract (New Window)

Ishitobi M. et al. (2012)

Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

April, 37(1), pp. 128-131.

Read Abstract (New Window)

Jain S. , Andridge R. , Hellings J. A. (2016)

Loxapine for reversal of antipsychotic-induced metabolic disturbances: A chart review.

Journal of Autism and Developmental Disorders

April, 46(4), pp.1344-1353.

Read Abstract (New Window)

Jesner O. S. , Aref-Adib M. , Coren E. (2007)

Risperidone for autism spectrum disorder.

Cochrane Database of Systematic Reviews

(1), CD005040

Read Abstract (New Window) Read Full (New Window)

Jobski K. et al. (2016)

Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.

Acta Psychiatrica Scandinavica

pp. 1-21.

Read Abstract (New Window)

Kemner C. et al. (2002)

Open-label study of olanzapine in children with pervasive developmental disorder.

Journal of Clinical Psychopharmacology

22 pp. 455-460

Read Abstract (New Window)

Kent J. M. et al. (2013)

An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

23(10), pp. 676-686.

Read Abstract (New Window)

King B. H. et al. (2009)

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

Archives of General Psychiatry

66(6), pp. 583-590

Read Abstract (New Window)

King B. et al. (2003)

Use of risperidone in a paediatric population: an observational study.

Journal of Paediatrics and Child Health

39(7), pp. 523-527

Read Abstract (New Window)

Kirino E. (2014)

Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children.

Clinical Medicine Insights: Pediatrics

May, 8 pp. 17-30.

Read Abstract (New Window) Read Full (New Window)

Knabe R. , Schultz P. , Richard J. (1990)

Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.

Journal of Autism and Developmental Disorders

20(4), pp. 591-593

Read Extract (New Window)

Kwon H. (2004)

Tardive dyskinesia in an autistic patient treated with risperidone.

American Journal of Psychiatry

161(4), pp. 757-758

Read Full (New Window)

Lemmon M. E. , Gregas M. , Jeste S. S. (2011)

Risperidone use in autism spectrum disorders: A retrospective review of a clinic-referred patient population.

Journal of Child Neurology

26(4), pp. 428-432

Read Abstract (New Window)

Lindsay R. L. et al. (2006)

Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study.

Journal of Intellectual and Developmental Disability

December, 31(4), pp. 204-209.

Read Abstract (New Window)

Locascio J. et al. (1991)

Factors related to haloperidol response and dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 119-126

Luby J. et al. (2006)

Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 575-587

Read Abstract (New Window)

Lucker J. R. (1998)

Is auditory training safe?

Journal of Autism and Developmental Disorders

28(3), p 267.

Mackintosh V. H. , Goin-Kochel R. P. , Myers B. J. (2012)

What do you like dislike about the treatments you're currently using? a qualitative study of parents of children with autism spectrum disorders.

Focus on Autism and Other Developmental Disabilities

27(1), pp. 51-60

Read Abstract (New Window)

Malone R. P. , Harvey J. A. (2008)

Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 221-222

Read Extract (New Window)